Bernadette Connaughton
Director · HALOZYME THERAPEUTICS, INC.
- 2025
- Oct 8, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Bernadette Connaughton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Matthew L. Posard - $2.61M in HALO purchases and sales in the last 12 months
- Cortney Caudill - $1.96M in HALO purchases and sales in the last 12 months
- Mahesh Krishnan - $548K in HALO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Bernadette Connaughton?
Bernadette Connaughton is a corporate insider, tracked as Director of HALOZYME THERAPEUTICS, INC. (HALO). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Bernadette Connaughton submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Bernadette Connaughton been buying or selling stock?
Recorded transactions: 0 open-market purchases and 12 open-market sales ($1.14M) across all tracked filings.
